MNL Group (Maqui New Life) is a Chilean nutraceutical company founded in 2010 as a spin-off from a scientific consortium. It specializes in the research, development, and commercialization of standardized Maqui Berry (Aristotelia chilensis) extracts for human and animal health. MNL Group develops three proprietary patented ingredients — Delphinol®, MaquiBright®, and Futerpenol® — trusted by 38 international partners across the USA, Latin America, Europe, and Asia.

Where is MNL Group based and where does it operate?

MNL Group is headquartered in Huechuraba, Santiago, Chile (Av. del Valle 576, of 504). It sources all Maqui Berries from the wild forests of Southern Chile and Patagonia, and has expanded commercially to the USA and Japan (2014), and Europe, Canada, and Brazil (2017). Today it serves 38 international clients across 4 continents.

What is MNL Group's One Health approach?

MNL Group operates under a 'One Health' philosophy that recognizes the interdependence between human well-being, environmental balance, and animal health. This translates into three commitments: developing science-backed natural extracts for human preventive health (Delphinol®, MaquiBright®); creating natural formulations for animal immunity and antibiotic reduction (Futerpenol®); and partnering with local Patagonian communities to ensure sustainable harvesting, biodiversity protection, and responsible resource management.

Who leads MNL Group's scientific research?

MNL Group's scientific research is led by Andrés Leschot, Chief Scientific Officer and Biochemical Engineer, who oversees over 15 years of R&D and clinical validation of Maqui Berry standardized extracts. The company also collaborates with leading research institutions including Universidad Austral de Chile (UACH), Universidad Católica de Valparaíso (PUCV), Pathovet, and Aquabench.

What are MNL Group's key milestones?

MNL Group's key milestones include: 2010 — founded in Chile as a scientific spin-off; 2014 — commercial expansion to USA and Japan; 2017 — entry into Europe, Canada, and Brazil markets; 2023 — 38 international clients across 4 continents; 2024 — new R&D investment in muscle-aging prevention and skin health, including patent PCT/IB2024/051136 for sarcopenia prevention.

Company

MNL GROUP (Maqui New Life) is a Chilean company dedicated to the research, development, and commercialization of standardized Maqui Berry extracts and complementary natural ingredients — nutraceutical solutions that support Human Health and Aqua Health & Performance.

Founded in 2010 as a spin-off from a scientific consortium, MNL GROUP combines natural ingredient sources, sustainability, and innovation to create nutraceutical ingredients with clinically proven benefits.

We work to offer natural, science-backed solutions that improve well-being while protecting the environment and empowering local communities in Patagonia.

Corporate

Human Health

Aqua Health & Performance

2006

International research consortium formed, focused on Maqui Berry science.

2010

MNL Group founded in Chile.

2013

Aqua Health & Performance program begins, targeting sanitary challenges in the salmon industry.

2014

Expansion to USA and Japan.

2017

Entry into Europe, Canada and Brazil markets.

2019

Commercial scale-up of Aqua Health & Performance solutions.

2021–2024

National and international patents secured.

2023

+30 international clients across 4 continents.

2024

R&D investment for muscle-aging and skin health.

2025–2026

Aqua Health & Performance consolidated as MNL Group's dedicated aquaculture division.

Claudio Rabuco

Co-Founder & COO | Industrial Engineer

Julio Giddings

Partner, Chairman | CEO

https://50538125.fs1.hubspotusercontent-na1.net/hubfs/50538125/julio-giddins-retrato-1.webp

Iván Mimica

Co-Founder & Strategic Director | US Tech Entrepreneur

https://50538125.fs1.hubspotusercontent-na1.net/hubfs/50538125/Ivan-Mimica.webp

Andrés Leschot

Chief Scientific Officer | Biochemical Engineer

https://50538125.fs1.hubspotusercontent-na1.net/hubfs/50538125/Andres-Leschot-1.webp

Cristián Moreno

General Manager Animal Health Division

https://50538125.fs1.hubspotusercontent-na1.net/hubfs/50538125/cristian-moreno.jpeg

Daniela Chávez

CMO | MKT & Digital Strategy Leader

Maqui Berry Science: From Patagonia to Global Health

About MNL Group

Our Purpose

To advance the science of Maqui Berry and complementary natural ingredients toward a future of interconnected well-being.

Science-Driven Innovation for Human Health and Aqua Health & Performance

HUMAN HEALTH

AQUA HEALTH & PERFORMANCE

Sustainable by Nature, Verified by Science

Healthy People

Healthy Animals

Healthy Environments

Our values

Driven by clinical research and standardized processes.

Balancing environmental care, resource renewal, and community well-being.

Creating value through natural, proven solutions for human and animal health.

15+ Years of Innovation

Leadership & Expertise

Partner with the Leaders in Maqui Berry Science